Provider: Thomson Reuters Stock Report
Amicogen Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.
Provider: Reuters Investment Profile
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.
Amicogen to acquire stake in KUMHO CHEMICAL INDUSTRY
Amicogen Inc:To acquire 69.54 pct stake (215,575 shares) in KUMHO CHEMICAL INDUSTRY LTD, which is engaged in manufacturing and sales of amino acid powder, to improve competitiveness.Transaction amount of 900 mln won.Expected transaction date of May 7.
Latest Key Developments in Biotechnology
- European Medicines Agency issues positive opinion, recommends full approval of Pharmacyclics Inc's Imbruvica for treatment of two blood cancers
- CanTx Inc and Novogen Ltd appoints contract manufacturing organizations to produce clinical batches of the experimental anti cancer drug
- Zhongyuan Union Stem Cell Bioengineering Co to set up joint venture
- Applied Genetic Technologies Crop announces pricing of public offering
- Share this
- Digg this